Key result
Management of a transvenous ICD in a patient undergoing surgical tricuspid valve repair requires multidisciplinary scrutiny to determine alternative cardiac rhythm management options.
Why the study?
When tricuspid valve repair or replacement is considered in patients with transvenous cardiac rhythm management devices and tricuspid regurgitation, managing the existing device system requires multidisciplinary evaluation of alternatives.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
This case highlights the multidisciplinary considerations and alternative cardiac rhythm management options required when a patient with a transvenous ICD undergoes tricuspid valve repair.
Tricuspid regurgitation is a widely recognised phenomenon in patients with transvenous cardiac rhythm management (CRM) devices. If tricuspid valve repair or replacement is to be considered, what to do with the existing CRM system requires scrutiny with multidisciplinary input. We present a case of multifactorial tricuspid regurgitation in a 48-year-old female with giant cell myocarditis and a transvenous implantable cardioverter-defibrillator (ICD). Key considerations in management and alternative CRM options are discussed.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2023) conducted a case report in Multifactorial tricuspid regurgitation and giant cell myocarditis with a transvenous ICD (n=1). Alternative cardiac rhythm management options was evaluated. Management of a transvenous ICD in a patient undergoing surgical tricuspid valve repair requires multidisciplinary scrutiny to determine alternative cardiac rhythm management options.
Synapse has enriched 10 related papers. Consider them for comparative context: